A Study to Investigate Use of Off-the-shelf Natural Killer (NK) Cells (SAR445419) in Relapsed/Refractory Acute Myeloid Leukemia

NCT05712278 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukaemia

Interventions

DRUG: SAR445419
DRUG: fludarabine
DRUG: cytarabine

Sponsor

Sanofi